These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10269318)

  • 1. Guidelines for phenytoin infusions.
    Tuttle CB
    Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin sodium solubility in three intravenous solutions.
    Pfeifle CE; Adler DS; Gannaway WL
    Am J Hosp Pharm; 1981 Mar; 38(3):358-62. PubMed ID: 7223749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids.
    Cloyd JC; Bosch DE; Sawchuk RJ
    Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of intravenous phenytoin sodium infusions.
    Gannaway WL; Wilding DC; Siepler JK; King JH; Lee-Ow A
    Clin Pharm; 1983; 2(2):135-8. PubMed ID: 6883941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and stability of diazepam injection following dilution with intravenous fluids.
    Morris ME
    Am J Hosp Pharm; 1978 Jun; 35(6):669-72. PubMed ID: 665679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of nasogastric administration methods for phenytoin.
    Cacek AT; DeVito JM; Koonce JR
    Am J Hosp Pharm; 1986 Mar; 43(3):689-92. PubMed ID: 3706323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization of three phenytoin preparations in intravenous solutions.
    Giacona N; Bauman JL; Siepler JK
    Am J Hosp Pharm; 1982 Apr; 39(4):630-4. PubMed ID: 7081239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommended standards of practice, policies, and procedures for intravenous therapy. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):660-3. PubMed ID: 7386473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of phenytoin solubility in intravenous admixtures: physicochemical theory.
    Newton DW; Kluza RB
    Am J Hosp Pharm; 1980 Dec; 37(12):1647-51. PubMed ID: 7446539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

  • 13. Solubility characteristics of diazepam in aqueous admixture solutions: theory and practice.
    Newton DW; Driscoll DF; Goudreau JL; Ratanamaneichatara S
    Am J Hosp Pharm; 1981 Feb; 38(2):179-82. PubMed ID: 7211883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative sum control charts for admixture quality control.
    Sanford RL
    Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing waste of prepared sterile products.
    Davis NM
    Hosp Pharm; 1985 Feb; 20(2):109-13, 117. PubMed ID: 10270310
    [No Abstract]   [Full Text] [Related]  

  • 19. A first-phase quality assurance program for intravenous admixture aseptic technique.
    Gurwich EL; Hanold L; Schaeffer P
    Hosp Pharm; 1982 Mar; 17(3):119-21. PubMed ID: 10255637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inline filtration on the potency of drugs administered intravenously.
    Rusmin S; Welton S; DeLuca P; DeLuca PP
    Am J Hosp Pharm; 1977 Oct; 34(10):1071-4. PubMed ID: 920741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.